Angiogenesis process contributes to the pathogenesis of B-cell chronic lymphocytic leukemia (B-CLL) being the levels of VEGFA and bFGF higher in patients than in healthy controls. The gene discussed is FGF2; the disease is B-cell chronic lymphocytic leukemia.